Directorate Change

GlaxoSmithKline PLC
13 February 2004

Issued - 13th February 2004, London




                         GlaxoSmithKline plc Announces

                       Changes to the Board of Directors


GlaxoSmithKline plc (GSK) announces that Dr Michele Barzach and Ambassador
Donald McHenry are to step down from the Board at the conclusion of the
Company's AGM on 17th May 2004. This follows the implementation of the New
Combined Code on Corporate Governance.


Commenting on the departures, Sir Christopher Hogg, Chairman of GSK, said " On
behalf of the Board, I would like to thank Michele and Don warmly for their
dedicated and effective service to GSK and its predecessor companies. I have
always valued their support and contribution and wish them well for the future"


Simon Bicknell

Company Secretary

13th February 2004



                      This information is provided by RNS
            The company news service from the London Stock Exchange